118 related articles for article (PubMed ID: 21508766)
1. Comparative performance of the 2009 International Federation of Gynecology and Obstetrics' staging system for uterine corpus cancer.
Koskas M; Rouzier R
Obstet Gynecol; 2011 May; 117(5):1225-1226. PubMed ID: 21508766
[No Abstract] [Full Text] [Related]
2. Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer.
Lewin SN; Herzog TJ; Barrena Medel NI; Deutsch I; Burke WM; Sun X; Wright JD
Obstet Gynecol; 2010 Nov; 116(5):1141-9. PubMed ID: 20966700
[TBL] [Abstract][Full Text] [Related]
3. Comparative Performance of the 2009 International Federation of Gynecology and Obstetrics' Staging System for Uterine Corpus Cancer.
Lewin SN; Wright JD
Obstet Gynecol; 2011 May; 117(5):1226. PubMed ID: 21705925
[No Abstract] [Full Text] [Related]
4. Metastatic large cell neuroendocrine carcinoma of the lung arising from the uterus: A pitfall in lung cancer diagnosis.
Ono K; Yokota NR; Yoshioka E; Noguchi A; Washimi K; Kawachi K; Miyagi Y; Kato H; Yokose T
Pathol Res Pract; 2016 Jul; 212(7):654-7. PubMed ID: 27113439
[TBL] [Abstract][Full Text] [Related]
5. Site-specific factors for cancer of the corpus uteri from SEER registries: collaborative stage data collection system, version 1 and version 2.
Jamison PM; Altekruse SF; Chang JT; Zahn J; Lee R; Noone AM; Barroilhet L
Cancer; 2014 Dec; 120 Suppl 23():3836-45. PubMed ID: 25412395
[TBL] [Abstract][Full Text] [Related]
6. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.
Rabban JT; Gilks CB; Malpica A; Matias-Guiu X; Mittal K; Mutter GL; Oliva E; Parkash V; Ronnett BM; Staats P; Stewart CJR; McCluggage WG
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S25-S39. PubMed ID: 30550482
[TBL] [Abstract][Full Text] [Related]
7. Juxtatumoral stromal reactions in uterine endometrioid adenocarcinoma and their prognostic significance.
Wei S; Conner MG; Zhang K; Siegal GP; Novak L
Int J Gynecol Pathol; 2010 Nov; 29(6):562-7. PubMed ID: 20881855
[TBL] [Abstract][Full Text] [Related]
8. Endometrial Carcinoma With Trophoblastic Components: Clinicopathologic Analysis of a Rare Entity.
Rawish KR; Buza N; Zheng W; Fadare O
Int J Gynecol Pathol; 2018 Mar; 37(2):174-190. PubMed ID: 28582346
[TBL] [Abstract][Full Text] [Related]
9. Obesity and Lymphovascular Invasion in Women with Uterine Endometrioid Carcinoma.
Kamal M; Burmeister C; Zhang Z; Munkarah A; Elshaikh MA
Anticancer Res; 2015 Jul; 35(7):4053-7. PubMed ID: 26124354
[TBL] [Abstract][Full Text] [Related]
10. [Explanations and discussions of the revised international federation of gynecology and obstetrics staging system 2009].
Shen K; Sun JH; Cao ZY
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):725-31. PubMed ID: 21176550
[No Abstract] [Full Text] [Related]
11. [Clinical significance of the revised international federation of gynecology and obstetrics staging system 2009].
Shen K; Peng P; Wu M
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):721-4. PubMed ID: 21176549
[No Abstract] [Full Text] [Related]
12. Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcoma.
Amant F; Vergote I
Gynecol Oncol; 2004 Apr; 93(1):272-3; author reply 273-4. PubMed ID: 15047252
[No Abstract] [Full Text] [Related]
13. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
14. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
[TBL] [Abstract][Full Text] [Related]
15. Synchronous occurrence of primary neoplasms of the uterus with mucinous carcinoma of the cervix and endometrioid carcinoma of the endometrium.
Sun HD; Lai CR; Yen MS; Wang PH
Taiwan J Obstet Gynecol; 2011 Sep; 50(3):377-8. PubMed ID: 22030058
[No Abstract] [Full Text] [Related]
16. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms.
Murray SK; Clement PB; Young RH
Am J Surg Pathol; 2005 Feb; 29(2):157-66. PubMed ID: 15644772
[TBL] [Abstract][Full Text] [Related]
17. The reproducibility of a binary tumor grading system for uterine endometrial endometrioid carcinoma, compared with FIGO system and nuclear grading.
Sagae S; Saito T; Satoh M; Ikeda T; Kimura S; Mori M; Sato N; Kudo R
Oncology; 2004; 67(5-6):344-50. PubMed ID: 15713989
[TBL] [Abstract][Full Text] [Related]
18. FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics.
Pecorelli S; Benedet JL; Creasman WT; Shepherd JH
Int J Gynaecol Obstet; 1999 Jan; 64(1):5-10. PubMed ID: 10190664
[No Abstract] [Full Text] [Related]
19. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
[TBL] [Abstract][Full Text] [Related]
20. The CD44v6-negative phenotype in high-grade uterine carcinomas correlates with serous histologic subtype.
Soslow RA; Shen PU; Isacson C; Chung MH
Mod Pathol; 1998 Feb; 11(2):194-9. PubMed ID: 9504691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]